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Short Review 
Modeling cell behavior: moving beyond intuition 
Mario Jolicoeur 
Canada Research Chair in Applied Metabolic Engineering, Department of Chemical Engineering, 
École Polytechnique de Montréal, P.O. box 6079, Centre-ville Station, Montréal, Québec, H3C 3A7, 
Canada; Email: mario.jolicoeur@polymtl.ca; Tel: +1-514-340-4711; Fax: +1-514-340-4159. 
Abstract: In the context of the launching of this new journal, we propose a forum to the community 
of researchers interested and involved in, or even simply questioning the why, what, how, and when 
of modeling cell or cell culture behavior. To start the discussion, we review some of the usual 
questions we are routinely asked on the pertinence of modeling cell behavior, and on who might 
benefit from conducting such work. To draw a global portrait, throughout this text we refer the reader 
to handbooks introducing the basics of modeling a biosystem, as well as to selected works that can 
help visualize the broad fields of applications. 
Keywords: Modeling cell behavior; Mathematical model; Cell metabolism 
 
1.  Why Modeling Cell Behavior? 
Each semester, I am systematically asked this question in my graduate and undergraduate 
courses. Since the major improvements in industrial biotech have came from cell engineering work, 
why should we spend time and effort developing complex mathematical models? The answer is 
obviously not straightforward or unique, and may differ depending on your respective research or 
industrial fields of interest. In fact, there are various examples to illustrate when the modeling of cell 
behavior is thought to provide a useful tool to address complex multifactorial problems. For instance, 
the Chinese Hamster Ovary (CHO) production cell platform is a very interesting case of study. This 
cell platform is now a key player on the industrial scene for the production of most biotherapeutics 
such as monoclonal antibodies (mAb) and other proteins [1,2]. Like microbial platforms, the most 
significant improvements in animal cell platforms’ productivity are generally still obtained from 
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genetic engineering work. One or a set of genes that are directly involved in the biochemical 
reactions sequence leading to the compound of interest are selected, usually intuitively, and their 
expression levels are altered aiming at their overexpression or silencing [2]. However, the results are 
often the opposite of what was expected, and it is common to perform several steps of successive 
screenings for cell engineering targets as well as for parental and recombinant cell lines. In fact, 
intuition can be poor counsel for this type of work since the cellular metabolism is highly interlinked 
and regulated, making the result of a genetic or environmental intervention, from the modification of 
medium composition or of culture conditions, usually unpredictable. In order to be fully expressed, 
the improved capacity of recombinant cell lines then requires the design of specific culture protocols, 
implying the optimization of culture medium composition and management, with the addition of 
specific compounds during a culture (e.g. under fed-batch or perfusion culture modes). Moreover, 
successful cell engineering work, combined with the engineering of culture media and of fed-batch 
(or perfusion) culture strategies, has been shown to lead to increased accumulation levels in mAbs 
from few mg/L (~1980) to over ~10 g/L the last few decades [1,2].  
Overall, the development of a highly productive bioprocess will thus rely on the cumulative 
success of a series of crucial steps, from the identification of a parental cell line of high productive 
potential and the identification of efficient target(s) of cell engineering, to the design of optimal 
culture media and culture management protocols enabling the maximization and maintenance of both 
cell productivity and viability all along a culture cascade. Furthermore, because each step has its 
specific set of selection criteria, the whole process is largely based on a multifactorial analysis of 
experimental data, which has encouraged the industry to develop high-throughput techniques to 
conduct massive assays (i.e., on a large scale in terms of the amount of treatments) varying 
experimental parameters at many levels [2]. However, although this approach makes it possible to 
scan an impressive set of conditions, high titer product accumulation does not guarantee the further 
scale-up of the process or the product quality (i.e., protein activity) [3]. Therefore, another question 
that arises is: “How can a complex mathematical model be of some help since high-throughput 
robotized screening platforms offer a massive assay capacity at a low cost per assay, allowing to 
screen for optimal culture media, high productive cell lines and target(s) for cell engineering works?” 
In this context of a multifactorial problem, attempts are now being made to develop predictive 
models capable of guiding interpretation of the resulting big datasets. Such models are thus expected 
to lead to major breakthroughs not only in the field of industrial biotechnology, but also in medical 
science for the study of metabolic diseases where huge multifactorial databases are available.  
2.  Modeling: A Matter of Objective Function 
A cell evolves and interacts within an environment that stimulates or inhibits its behavior via 
various compounds and physico-chemical conditions (Figure 1), which all usually vary with time. In 
many biosystems, the use of the so-called “basic” cell culture dataset, which normally includes 
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biomass cell concentration or optical density, and the concentration of the limiting substrate and the 
product suffice to describe cell growth behavior, as well as the substrate consumption and product 
production rates. However, access is now available to various and complementary “omics” data 
enabling the characterization of almost the entire cell content, biochemical reactions stoichiometry 
and dynamics. The temptation can thus be great to “jump on” these big datasets, but is it always 
necessary? A decision map (Figure 2) can be drawn to help select a modeling approach depending on 
your specific objective function. The graduated levels, inspired from Bloom’s learning taxonomy, 
show that knowledge acquisition and mathematical development can be significant, but the model 
complexity you will need should always depend on your specific objective function. 
 
Figure 1. A cell environment. 
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Figure 2. Modeling levels of cell behaviour. 
If you are simply aiming at characterizing the effect of an environment on a cell’s macroscopic 
behavior, you may want to start at modeling level 1, limiting your observations to traits such as cell 
viability, growth type and which compounds are consumed and released by the cells. Otherwise, if 
your goal is to characterize the interaction of cells with their environment, then you should be at 
level 2 and should sample and/or monitor the biosystem and acquire the experimental data necessary 
to compute parameters such as cell growth (or division) rate, cell yields on the major nutrients, 
nutrients consumption, and metabolites secretion rates (often called as wastes). There is abundant 
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literature available for those interested in this approach and I suggest reading the early chapters of 
classic handbooks such as Pirt (1968) [4] and Bailey and Ollis (1986) [5]. With these data, you can 
develop a mathematical system made of mass balances describing the time variations of the various 
culture parameters for which you have experimental data. These mass balances are essentially 
differential equations accounting for the consumption of nutrients, the production of the compound 
of interest and cell growth. Since an important issue at that level is to describe reaction kinetics, the 
Monod (1959) [6] equation is still pertinent and useful, along with others that have since been 
developed [5].  
At level 2 you basically obtain a simulator of macroscopic cell behavior, which requires you to 
know only about initial culture conditions at time “0.” The numerical integration of the system of 
differential equations using commercial software will do the rest, drawing a projection in time of the 
state of a culture. However, although level 2 is highly sufficient for many biosystems, in the case of 
cells accumulating compounds (e.g. plant cells [7, 8]), or those composed of a set of sub-populations 
that need to be described, you may need to move on to level 3. The model is more complex at that 
level, but that is the cost of being able to describe complex cell populations. 
If you systematically experience discrepancies between model simulations and your datasets, 
you may need to move further in describing a cell behavior by looking closely at the reaction level 
inside the cells. You are then at level 4 and focusing on cell metabolic organization. It is then crucial 
that the experimental design limits physiological stresses from the cell environment (Figure 1), or 
includes their description in the model. Knowing the stoichiometry of the enzymatic reactions you 
are describing, you can build up a set of mass balance equations, one per enzymatic reaction, limiting 
your study to steady state or quasi steady state biosystems. This approach allows for the performance 
of the Metabolic Flux Analysis (MFA) [9] of a biosystem, linking compounds in the cell 
environment to their intracellular processing through the metabolic network of enzymatic reactions. 
Adding adequate hypotheses or “constraints,” you can draw the space of solutions for your 
biosystem and thus evaluate the “potential” of the cells under study using the Metabolic Flux 
Balance Analysis (MFBA) [10].  
When reversible biochemical reactions need to be analyzed, various labeled substrates (e.g., 13C, 
15N, 31O, etc.) can be fed to the cells and the effective flux determined [9]. If you can perform 
specific cell engineering work modifying an enzyme activity level, you can then perform what is 
called a Metabolic Control Analysis (MCA) [11], and thus evaluate the metabolic flexibility or 
rigidity of the cells under study. At that level, you can estimate the flux distribution within a defined 
metabolic network. Thus, knowing the stoichiometry of the metabolic reactions, you know where 
carbon flows and at what rates. This is very useful since it can tell you about potential bottlenecks 
limiting or diverging the carbon flow from the biosynthetic pathways leading to your product of 
interest or towards any of your objective functions. Combined with MCA, you can then locate 
potential targets of cell engineering works enabling the carbon to be redirected towards your 
objective function (e.g., cell growth rate, production or other). However, if you are looking for a 
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predictive capacity of cell behavior, MFBA appears to offer some potential [12], although you may 
need to move on to the next modeling level.  
By predictive capacity you may understand “in time”, such as in transient processes or where 
perturbations occur, both cases that are normally encountered in many biosystems. You are then at 
level 5 where the complexity of this approach may become significant but the outcomes are worth it 
in many cases. The complexity of the approach involves not only mathematical work, but also, and 
primarily, obtaining the required experimental data. You need to quantify the cell intracellular 
content in metabolites and intermediate metabolites, data obtained using cell extraction protocols that 
must be highly efficient at quenching the cell metabolism in order to stop enzymatic reactions. The 
samples are then analyzed using sophisticated and expensive equipment with various detectors such 
as mass spectrometry [13,14] and nuclear magnetic resonance (NMR) [14,15]. With this approach, 
because you have experimental datasets as well as culture time, you can address the description of 
transient behaviors of metabolic events, although there is a high labor cost involved in describing the 
biochemical reaction kinetics, implying a set of kinetic parameters to be determined for each 
enzymatic reaction. In many cases, such parameters cannot be found in the literature or in databanks 
(e.g., BRENDA, brenda-enzymes.info [16] and references therein). And if you do find any, they may 
have been determined in vitro, meaning they may not correspond to the intracellular conditions of 
your biosystem.  
The parameters that are not described in the literature and databanks have to be determined 
from estimations, while minimizing model simulation error compared to experimental data. 
Although the process may be quite laborious when the parameter number to be estimated is high, 
parameter values can still be identified following standard statistical analysis of the confidence 
intervals. Considering that such a model consists in a simplification of the biosystem’s metabolism, it 
is understood that the estimated kinetic parameter values can hardly be those of the enzymes in 
action; the more detailed a model described, the closer the parameter values to the real conditions.  
In order to avoid or limit this problem, hybrid approaches have been proposed accounting for a 
limited set of transient reactions while keeping others at steady state [17,18]. However, these 
approaches show limited predictive capacity, requiring periodic re-scaling steps on freshly obtained 
experimental data. To be qualified as predictive, a model should be able to simulate cell behavior in 
time from defining initial conditions, including that of the cells. Such an in silico platform can be 
invaluable to perform complex tasks such as evaluating various medium compositions and medium 
feeding strategies. A dynamic MFC (dMFC) study can then be conducted to assess “optimal” culture 
strategies. For instance, the objective function can then consist in seeking to maximize carbon flow 
along pathways leading to a product synthesis, or for any other metabolic event. This process of 
simulating how each flux rate or their ratios evolve with time can also lead to the identification of 
specific biomarkers of a cell’s physiological state, which can then be translated into a defined 
combination of culture parameters that can be monitored to probe specific biosystem’s metabolic 
states (e.g., growth and/or production). Even from a limited set of experimental data, metabolic 
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changes occurring with time and culture perturbations can thus be studied [19]. Accordingly, these 
studies can be extremely useful for improving our understanding of the cell’s intracellular dynamics 
against changes and perturbations in its environment [20,21].  
However, the key to obtaining a predictive model may lie in the description of the various 
metabolic pathway regulation phenomena, which enable cell survival within a changing environment. 
At such a high level of modeling, dynamic MCA (dMCA) analysis can start to be performed, testing 
hypothesis of targets for cell engineering work. Some attempts to use such data-driven models have 
also been conducted to assist in defining real-time fed-batch culture strategies to control CHO [17] 
and plant cells’ metabolic state [22,23], to study the effect of a genetic modification on potato cell 
behavior [24], and to study the role of energetic robustness in mice model of Parkinson’s  
disease [25]. However, these studies were limited within known experimental spaces. As expected, 
the closer a model describes a cell’s machinery, the better its predictive capacity, and at that 
complexity level the outputs (i.e., simulations) of a model should still be taken as hypothetic 
predictions. 
If your objective function is to be able to modulate cell metabolism making “live” real-time 
decisions on the management of a cell environment, you then need to climb to level 6. Although at a 
lower level (i.e., from level 4), you can increase the model’s predictive capacity by including some 
knowledge on proteomics, interactomics, expressomics and genomics, at level 6 this step is 
mandatory. It may also be required to account for physiological aspects such as those described in 
Figure 1. The aim here is to provide a model predictive capacity that can go beyond a known 
experimental space. Such a modeling level is thus expected to allow for the identification of optimal 
cell metabolism and cell culture management, including exploring hypotheses of therapies and 
biomedical approaches such as regenerative medicine. 
3.  Modeling Approaches vs. Biosystems 
How much should modeling approaches differ among biosystems? This is an important question 
that arises when initiating modeling work on a cell type with which we are unfamiliar. The normal 
reflex is to consider that they are all specific enough to require a distinct modeling approach. Cell 
genetics obviously differs among species, as do the resulting metabolomics, with different 
intermediate metabolites and enzymes concentration and diversity, as well as the rate and regulation 
of metabolic fluxes. However, the cell metabolism of all cell species (to the best of our knowledge) 
obeys to similar kinetic laws with many pathways that have been preserved along with cell species 
evolution. In fact, the literature provides studies using a unique modeling approach for diverse cell 
platforms. However, it has been clear since the Monod model of exponential growth has been 
efficiently applied to every cell platform—from microbial to animal cells—that all cell types 
undergoing division macroscopically behave similarly, showing a direct relationship with the 
limiting nutrient concentration. There are of course numerous cases for which the Monod model does 
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not adequately apply when based on extracellular substrates. For instance, the plant cell platform, 
which shows a nutrient accumulation capacity, requires a model that accounts for a limiting substrate 
within the intracellular volume [8]. As previously mentioned, MFA, MFBA and MCA approaches, 
as well as their dynamic forms, have been applied to bacteria, yeasts, fungi, plant and animal cells. 
Therefore, after being “frame fitted” to cell species specificities, a model can be built integrating 
known enzyme kinetic formulations, thus accounting for the cell line specific dynamics. 
4. Steady State vs. Transient: A Matter of Set-points and Regulation 
As Figure 1 shows, a cell is a social entity continuously interacting with its environment to 
survive. This interaction, driven through the actions/reactions of the cell’s metabolic network, aims 
at maintaining intracellular conditions favoring the life continuum we call "viability". During its 
living state, a cell has thus to ensure the controlled uptake and secretion of specific compounds to 
enable various functions such as the regulation of intracellular osmolality and pH (which can both 
vary among organelles and cytosolic volumes), the uptake of precursors and co-factors to feed the 
pathways responsible for the biosynthesis of metabolic intermediates and energy production, and 
also deal with crucial signaling events. These cell "objective functions", along with others that are 
not mentioned here, are logically interlinked and can thus be highly challenged by the various 
stresses occurring along a cell culture, such as external variations of physical parameters 
(temperature, pH, light, osmolality, etc.), nutrients concentration or even mechanical stresses, and so 
on. The mechanisms of action (or reaction) a cell has to survive in a changing environment may 
differ among microbial, yeast, plant and mammalian cell platforms, but the literature suggests they 
possess a common set of tools [26].  
With this global picture in mind, it becomes obvious that describing a cell population at steady 
state is a specific case study that provides only a partial view of a biosystem. In fact, the phenomena 
influencing or involved in cell behavior occur under a wide range of characteristic times (Figure 3). 
It is thus expected that the phenomena with a fast dynamic, which are tedious to observe because of 
technical limitations in sampling and monitoring, may trigger a change in the long-term cell behavior. 
Moreover, it is also common to perform studies under the quasi steady state hypothesis, and if the 
latter is mathematically verified comparing the characteristic times involved, there can be 
imperceptible underlying physiological changes inducing a strong bias in the conclusions that are 
drawn.  
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Figure 3. Time scales affecting cell behaviour. 
Therefore, although it is extremely important to identify the steady states a cell is able to 
maintain when facing varying environmental conditions, it may be useful to characterize how a cell 
maintains each steady state and how the biosystem evolves within multi steady states. Moreover, it 
should not be forgotten that at certain steps of any bioprocess (or simply cell culture) the cells will 
experience transient conditions. In each bioprocess, the early stage of cell culture build-up before the 
production bioreactor is usually performed in a cascade of bioreactors run in batch mode, which is 
mostly transient. In the biomedical field, the culture of tissues or cells in regenerative medicine 
normally involves batch culture mode, and the cells go through highly stressful transient processes 
when grown onto biomaterials. In a context of producing a biotherapeutic compound, this behavior 
change may result in a loss in cell productivity. In a biomedical (or medical) context, it may trigger 
cell differentiation from a desired to a pathological phenotype. MFA and MFBA approaches have 
proved to be useful for estimating flux distribution in a network at steady and quasi steady state 
conditions, but dynamic studies (dMFA and dMFBA) are thought to allow for the evaluation of the 
various impacts of potential dynamic events, as well as enabling MCA studies on a biosystem, 
characterizing cell behavior under specific perturbations. Therefore, following a system's biology 
approach, basic knowledge on cell intracellular dynamics and its potential effects on cell metabolism 
should be integrated. This knowledge, together with the description of the mechanisms involved, will 
be more than helpful in the development of a descriptive modeling framework that has a predictive 
capacity. 
5.  What Should We Expect From A Mathematical Model of Cell Behavior?  
The usefulness of modeling cell behavior may now be clearer, and we hope that the resulting 
mathematical model derived from such work will be considered as an invaluable tool to identify 
innovative solutions in various cases. Such in silico platforms can offer an innovative tool not only 
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for the optimization of bioprocesses, but also in medicine to simulate hypotheses on therapeutics and 
therapy strategies, as well as in biomedical engineering, for instance, to better understand the 
problem of losing a desired cell phenotype when using multipotent cells. Although these contexts 
differ in their research paradigm, the modeling tools developed in each case may be much more 
similar than might be thought.  
Thus, overall, what can we expect from a metabolic model? First, it can definitely contribute to 
the characterization of a biosystem behavior. However, to be considered as an in silico platform, a 
model has to demonstrate a predictive capacity. As shown in Figure 2, obtaining a predictive 
capacity is an ultimate goal, which is expected to be costly in terms of time and effort, as well as 
financially, taking analytics into account. Nonetheless, such an in silico platform can then help save 
time and effort and thus accelerate a research project’s success in meeting its objective function(s), 
such as optimizing a medium composition or fed-batch (or perfusion) culture strategy (i.e. bioreactor 
control) or identifying “optimal” parental cell lines or robust high-producer clones. As mentioned 
earlier however the use of a model to identify targets of cell engineering, to test hypotheses on the 
effect of a therapeutic or a therapy strategy, and to simulate cell differentiation processes may require 
the contribution of full “omics” technologies.  
In fine, it is thought that our capacity to describe the various cell dynamics that affect cell 
behavior will enable a model’s predictive capacity. However, the question of how important it is to 
remain close to a biologically relevant description of cell mechanisms while developing 
mathematical models still remains. The more “biological” a model, the more tedious it could be to 
statistically validate it with full parameter identification, but this may be the price to pay for a model 
that could demonstrate a predictive capacity enabling us to explore outside the comfort zone of 
known experimental conditions, and thus move beyond intuition.  
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